IITRI is pleased to announce the expansion of our infectious disease immunology capabilities with the recent hiring of Justin Richner, PhD, to the position of Research Biologist, Viral Immunology. Dr. Richner’s research focus includes viral pathogenesis and host immune responses of rodent, large animal, and nonhuman primate (NHP) models. Dr. Richner also brings expertise in flow cytometry, introducing new immunophenotyping and cytochemistry capabilities to IITRI.

The expansion into the field of immunology strengthens IITRI’s capacity to deliver preclinical services for the development of novel therapeutic and prophylactic antiviral measures.

Dr. Richner completed his PhD in Microbiology from the University of California Berkeley where he investigated viral pathogenesis and the molecular biology of herpesviruses. He continued his training as a postdoctoral fellow at Washington University in St. Louis School of Medicine, where he studied the host immune response to various RNA viruses including West Nile virus, Japanese Encephalitis virus and Dengue viruses, as well as the recently emerged Chikungunya and Zika viruses. Dr. Richner’s research has included the development of antiviral vaccines and therapeutics in small animal models to combat these viruses, and he has authored over 20 peer-reviewed manuscripts.